These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7572316)

  • 1. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats.
    Katsumata T; Nakamura T; Ohnishi H; Sakurama T
    J Bone Miner Res; 1995 Jun; 10(6):921-31. PubMed ID: 7572316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of indomethacin reduces vertebral bone mass and strength in ovariectomized rats.
    Saino H; Matsuyama T; Takada J; Kaku T; Ishii S
    J Bone Miner Res; 1997 Nov; 12(11):1844-50. PubMed ID: 9383689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates clodronate and etidronate in the prevention of ovariectomy-induced osteopenia in growing rats.
    Lepola VT; Kippo K; Hannuniemi R; Laurén L; Virtamo T; Osterman T; Jalovaara P; Sellman R; Väänänen HK
    J Bone Miner Res; 1996 Oct; 11(10):1508-17. PubMed ID: 8889851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
    Motoie H; Nakamura T; O'uchi N; Nishikawa H; Kanoh H; Abe T; Kawashima H
    J Bone Miner Res; 1995 Jun; 10(6):910-20. PubMed ID: 7572315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
    Jiang Y; Zhao J; Genant HK; Dequeker J; Geusens P
    J Bone Miner Res; 1997 May; 12(5):820-31. PubMed ID: 9144349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotine on bone mass and strength in aged female rats.
    Akhter MP; Iwaniec UT; Haynatzki GR; Fung YK; Cullen DM; Recker RR
    J Orthop Res; 2003 Jan; 21(1):14-9. PubMed ID: 12507575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of combined treatment with etidronate and alfacalcidol on bone mass and mechanical properties in ovariectomized rats.
    Nishikawa T; Ogawa S; Kogita K; Manabe N; Katsumata T; Nakamura K; Kawaguchi H
    Bone; 2000 Nov; 27(5):647-54. PubMed ID: 11062351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial prevention of long-term femoral bone loss in aged ovariectomized rats supplemented with choline-stabilized orthosilicic acid.
    Calomme M; Geusens P; Demeester N; Behets GJ; D'Haese P; Sindambiwe JB; Van Hoof V; Vanden Berghe D
    Calcif Tissue Int; 2006 Apr; 78(4):227-32. PubMed ID: 16604283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual and combined effects of exercise and alendronate on bone mass and strength in ovariectomized rats.
    Fuchs RK; Shea M; Durski SL; Winters-Stone KM; Widrick J; Snow CM
    Bone; 2007 Aug; 41(2):290-6. PubMed ID: 17544352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of continuous alendronate treatment on bone mass and mechanical properties in ovariectomized rats: comparison with pamidronate and etidronate in growing rats.
    Azuma Y; Oue Y; Kanatani H; Ohta T; Kiyoki M; Komoriya K
    J Pharmacol Exp Ther; 1998 Jul; 286(1):128-35. PubMed ID: 9655851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in bone histomorphometry after long-term treatment with intermittent, cyclic etidronate for postmenopausal osteoporosis.
    Storm T; Steiniche T; Thamsborg G; Melsen F
    J Bone Miner Res; 1993 Feb; 8(2):199-208. PubMed ID: 8442438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of sodium daidzein sulfonate on trabecular bone in ovariectomized rats.
    Ren P; Ji H; Shao Q; Chen X; Han J; Sun Y
    Pharmacology; 2007; 79(3):129-36. PubMed ID: 17179740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of administration of retinol and etidronate on bone histomorphometric parameters in ovariectomized rats.
    Kaczmarczyk-Sedlak I; Pytlik M; Sliwińiski L; Nowińska B; Juszczyk J
    Acta Pol Pharm; 2004; 61(5):383-91. PubMed ID: 15747696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y; Baytur Y; Inceboz U; Demir BC; Gumuser G; Ozbilgin K
    Maturitas; 2009 Jul; 63(3):261-7. PubMed ID: 19386450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.